Dolby Laboratories, Inc.
DLB
$75.60
-$0.19-0.25%
NYSE
| 12/27/2024 | 09/27/2024 | 06/28/2024 | 03/29/2024 | 12/29/2023 | |
|---|---|---|---|---|---|
| Revenue | 357.00M | 304.81M | 288.82M | 364.52M | 315.57M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 357.00M | 304.81M | 288.82M | 364.52M | 315.57M |
| Cost of Revenue | 40.77M | 34.00M | 35.66M | 38.78M | 32.06M |
| Gross Profit | 316.23M | 270.81M | 253.16M | 325.75M | 283.51M |
| SG&A Expenses | 164.49M | 157.11M | 146.79M | 156.78M | 144.17M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 271.90M | 259.74M | 247.96M | 258.05M | 243.26M |
| Operating Income | 85.10M | 45.06M | 40.86M | 106.47M | 72.31M |
| Income Before Tax | 86.05M | 59.73M | 50.16M | 121.75M | 80.83M |
| Income Tax Expenses | 17.98M | 868.00K | 10.51M | 23.53M | 13.25M |
| Earnings from Continuing Operations | 68.07M | 58.87M | 39.66M | 98.21M | 67.58M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -248.00K | -296.00K | -1.21M | -384.00K | -600.00K |
| Net Income | 67.82M | 58.57M | 38.44M | 97.83M | 66.98M |
| EBIT | 85.10M | 45.06M | 40.86M | 106.47M | 72.31M |
| EBITDA | 107.46M | 66.42M | 59.17M | 124.49M | 90.18M |
| EPS Basic | 0.71 | 0.61 | 0.40 | 1.02 | 0.70 |
| Normalized Basic EPS | 0.59 | 0.38 | 0.34 | 0.77 | 0.56 |
| EPS Diluted | 0.70 | 0.60 | 0.40 | 1.01 | 0.69 |
| Normalized Diluted EPS | 0.58 | 0.37 | 0.34 | 0.76 | 0.55 |
| Average Basic Shares Outstanding | 95.62M | 95.40M | 95.69M | 95.72M | 95.38M |
| Average Diluted Shares Outstanding | 97.15M | 96.59M | 96.96M | 96.86M | 97.44M |
| Dividend Per Share | 0.33 | 0.33 | 0.30 | 0.30 | 0.30 |
| Payout Ratio | 46.52% | 48.84% | 74.66% | 29.35% | 42.63% |